Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas
- Author
- EBERLEIN, Klaus H1 ; NAGEL, Britta1 ; FRANZ, Kea2 ; IMHOFF, Detlef1 ; SEIFERT, Volker2 ; BOETTCHER, Heinz D1 ; MOSE, Stephan3
[1] Department of Radiotherapy and Oncology, Johann Wolfgang Goethe-Universität Frankfurt/Main, Frankfurt, Germany
[2] Department of Neurosurgery, Johann Wolfgang Goethe-Universität Frankfurt/Main, Frankfurt, Germany
[3] Radiotherapy Department, Villingen-Schwenningen Hospital, Villingen-Schenningen, Germany - Source
Anticancer research. 2006, Vol 26, Num 6C, pp 4959-4964, 6 p ; ref : 51 ref
- ISSN
- 0250-7005
- Scientific domain
- Medical oncology
- Publisher
- International Institute of Anticancer Research, Attiki
- Publication country
- Greece
- Document type
- Article
- Language
- English
- Author keyword
- Malignant glioma glioblastoma multiforme high-grade glioma radiochemotherapy survival temozolomide
- Keyword (fr)
- Anticancéreux Cancérologie Chimioradiothérapie Glioblastome multiforme Gliome malin Haut grade Haute malignité Homme Stade précoce Survie Témozolomide Agent alkylant Système nerveux central pathologie Système nerveux pathologie Tumeur maligne
- Keyword (en)
- Antineoplastic agent Cancerology Chemoradiotherapy Glioblastoma multiforme Malignant glioma High grade High malignancy Human Early stage Survival Temozolomide Alkylating agent Central nervous system disease Nervous system diseases Malignant tumor
- Keyword (es)
- Anticanceroso Cancerología Quimioradioterapia Glioblastoma multiforme Glioma maligno Alto grado Alta malignidad Hombre Estadio precoz Sobrevivencia Temozolomida Agente alquilante Sistema nervosio central patología Sistema nervioso patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17E Tumors of the nervous system. Phacomatoses
- Discipline
- Neurology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18373685
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"6C\";s:8:\"\u0000*\u0000spage\";s:4:\"4959\";s:8:\"\u0000*\u0000epage\";s:4:\"4964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"EBERLEIN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Klaus H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"NAGEL, Britta\";i:1;s:10:\"FRANZ, Kea\";i:2;s:14:\"IMHOFF, Detlef\";i:3;s:15:\"SEIFERT, Volker\";i:4;s:18:\"BOETTCHER, Heinz D\";i:5;s:13:\"MOSE, Stephan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"6C\";s:8:\"\u0000*\u0000spage\";s:4:\"4959\";s:8:\"\u0000*\u0000epage\";s:4:\"4964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"EBERLEIN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Klaus H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"NAGEL, Britta\";i:1;s:10:\"FRANZ, Kea\";i:2;s:14:\"IMHOFF, Detlef\";i:3;s:15:\"SEIFERT, Volker\";i:4;s:18:\"BOETTCHER, Heinz D\";i:5;s:13:\"MOSE, Stephan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"6C\";s:8:\"\u0000*\u0000spage\";s:4:\"4959\";s:8:\"\u0000*\u0000epage\";s:4:\"4964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"EBERLEIN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Klaus H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"NAGEL, Britta\";i:1;s:10:\"FRANZ, Kea\";i:2;s:14:\"IMHOFF, Detlef\";i:3;s:15:\"SEIFERT, Volker\";i:4;s:18:\"BOETTCHER, Heinz D\";i:5;s:13:\"MOSE, Stephan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:2:\"6C\";s:8:\"\u0000*\u0000spage\";s:4:\"4959\";s:8:\"\u0000*\u0000epage\";s:4:\"4964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"EBERLEIN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Klaus H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"NAGEL, Britta\";i:1;s:10:\"FRANZ, Kea\";i:2;s:14:\"IMHOFF, Detlef\";i:3;s:15:\"SEIFERT, Volker\";i:4;s:18:\"BOETTCHER, Heinz D\";i:5;s:13:\"MOSE, Stephan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
